5-Year Outcomes with Cobimetinib plus Vemurafenib in <i>BRAF</i> V600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study

Paolo A. Ascierto, Grant A. McArthur, Mario Mandalà et al.|Clinical Cancer Research|2021

Cited by 182